Who owns Oric Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ORIC from SEC Form 13F filings across 180 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 180 institutions disclosed 123.5M shares of Oric Pharmaceuticals, Inc. worth $1.34B — about 114.4% of shares outstanding; the largest disclosed holder is Nextech Invest Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
180
13F holders
$1.34B
value, 2026 filers
114.4%
of shares outstanding (123.5M sh)
30
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ORIC's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Nextech Invest Ltd. | 7.2M | $77.6M | 3.7% | 6.6% | 0.0% |
| 2 | BlackRock, Inc. | 6.8M | $73.9M | 0.0% | 6.3% | +14.0% |
| 3 | EcoR1 Capital, LLC | 6.7M | $72.9M | 3.5% | 6.2% | 0.0% |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 6.6M | $71.7M | 0.0% | 6.1% | +22.8% |
| 5 | VIKING GLOBAL INVESTORS LP | 5.1M | $55.5M | 0.2% | 4.7% | -12.0% |
| 6 | STATE STREET CORP | 4.9M | $53.0M | 0.0% | 4.5% | +32.2% |
| 7 | SR One Capital Management, LP | 4.6M | $50.0M | 4.8% | 4.3% | +2.2% |
| 8 | Venrock Adviser, LLC | 4.3M | $46.8M | 1.4% | 4% | 0.0% |
| 9 | NEA Management Company, LLC | 4.1M | $44.6M | 2.8% | 3.8% | 0.0% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0M | $42.8M | 0.0% | 3.7% | +7.2% |
| 11 | AIHC Capital Management Ltd | 3.8M | $41.5M | 39.8% | 3.5% | +55.7% |
| 12 | ALKEON CAPITAL MANAGEMENT LLC | 3.7M | $40.5M | 0.1% | 3.5% | -17.0% |
| 13 | Column Group LLC | 3.5M | $38.3M | 43.5% | 3.3% | 0.0% |
| 14 | Siren, L.L.C. | 3.0M | $32.5M | 0.7% | 2.8% | 0.0% |
| 15 | FMR LLC | 2.6M | $28.5M | 0.0% | 2.4% | +8.3% |
| 16 | CITADEL ADVISORS LLC | 2.6M | $28.1M | 0.0% | 2.4% | +7.1% |
| 17 | GOLDMAN SACHS GROUP INC | 2.5M | $26.6M | 0.0% | 2.3% | +66.1% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $22.6M | 0.0% | 1.9% | +13.7% |
| 19 | First Turn Management, LLC | 2.0M | $21.8M | 2.3% | 1.9% | 0.0% |
| 20 | ORBIMED ADVISORS LLC | 2.0M | $21.8M | 0.4% | 1.9% | -25.2% |
| 21 | Integral Health Asset Management, LLC | 1.9M | $20.6M | 0.8% | 1.8% | +35.7% |
| 22 | MPM BIOIMPACT LLC | 1.9M | $20.4M | 1.2% | 1.7% | +4.3% |
| 23 | Vivo Capital, LLC | 1.8M | $20.0M | 1.8% | 1.7% | 0.0% |
| 24 | DIMENSIONAL FUND ADVISORS LP | 1.8M | $19.5M | 0.0% | 1.7% | +22.4% |
| 25 | FRANKLIN RESOURCES INC | 1.8M | $19.5M | 0.0% | 1.7% | +23.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.